Double Exclusive Use MAD. 1  Superior Room 6,550. 2  Deluxe Room 8,250. 3  Superior Suite 9,550. 4  Deluxe Suite 11,000. 5  Berber Tent 11,000. 6  Deluxe Pool Suite 13,250. 7  Berber Tent with private jacuzzi 13,250. 8  Master Suite 28,000.
How KadcylaTM (ado-trastuzumab emtansine) is Believed to Work (Proposed Mechanism of Action) Kadcyla is the first Genentech antibody-drug conjugate (ADC) to receive FDA approval. Kadcyla combines the mechanisms of action of trastuzumab (the antibody in Herceptin) and the chemotherapy, DM1, in one medicine. 1. Kadcyla is made up of the antibody, trastuzumab, and the chemotherapy, DM1, joined together using a stable linker. , 2. Kadcyla binds to HER2-positive cells and is thought to block out-of-control signals that make the cancer grow while also calling on the bodyâs immune system to attack the cancer cells., 3.
âKeytruda is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression [Tumor Proportion Score (TPS) â¥50%)] as determined by an FDA-approved test, with no EGFR or ALK genomic tumor aberrations [see Clinical Studies (14.2)].